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Abstract
Background: The number of studies regarding the incidence of multidrug resistant strains and distribution of
genes encoding virulence factors, which have colonized the post-Soviet states, is considerably limited. The aim of
the study was (1) to assess the Staphylococcus (S.) aureus nasal carriage rate, including Methicillin Resistant S. aureus
(MRSA) strains in adult Ukrainian population, (2) to determine antibiotic resistant pattern and (3) the occurrence of
Panton Valentine Leukocidine (PVL)-, Fibronectin-Binding Protein A (FnBPA)- and Exfoliative Toxin (ET)-encoding
genes.
Methods: Nasal samples for S. aureus culture were obtained from 245 adults. The susceptibility pattern for several
classes of antibiotics was determined by disk diffusion method according to the European Committee on Antimicrobial
Susceptibility Testing (EUCAST) guidelines. The virulence factor encoding genes, mecA, lukS-lukF, eta, etb, etd, fnbA, were
detected by Polymerase Chain Reaction (PCR).
Results: The S. aureus nasal carriage rate was 40%. The prevalence of nasal MRSA carriage in adults was 3.7%.
LukS-lukF genes were detected in over 58% of the strains. ET-encoding genes were detected in over 39% of the
strains and the most prevalent was etd. The fnbA gene was detected in over 59% of the strains. All MRSA isolates
tested were positive for the mecA gene. LukS-lukF genes and the etd gene were commonly co-present in MRSA,
while lukS-lukF genes and the fnbA gene were commonly co-present in Methicillin Sensitive S. aureus (MSSA)
isolates. No significant difference was detected between the occurrence of lukS-lukF genes (P > 0.05) and the etd
gene (P > 0.05) when comparing MRSA and MSSA. The occurrence of the fnbA gene was significantly more
frequent in MSSA strains (P < 0.05).
Conclusions: In Ukraine, S. aureus is a common cause of infection. The prevalence of S. aureus nasal carriage in our
cohort of patients from Ukraine was 40.4%. We found that 9.1% of the strains were classified as MRSA and all MRSA
isolates tested positive for the mecA gene. We also observed a high prevalence of PVL- and ET- encoding genes among
S. aureus nasal carriage strains. A systematic surveillance system can help prevent transmission and spread of
drug resistant toxin producing S. aureus strains.
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Background
Nasal colonization is the cause of recurrent staphylococcal
infections. The host tissue colonization by Staphylococcus
(S.) aureus is an important factor in disease pathogenesis.
S. aureus expresses Fibronectin-Binding Protein A (FnBPA),
which mediates the adhesion to fibrinogen, elastin and fibro-
nectin [1]. The pathogenicity of S. aureus results from
its ability to produce specific toxins and hydrolytic en-
zymes. Some S. aureus strains can produce Panton-
Valentine Leucocidin (PVL), which can cause tissue
necrosis and leukocyte lysis [2]. PVL is a bi-component
leucotoxin composed of S-related and F-related proteins
that are separately secreted, but act synergistically. The
Exfoliative Toxins (ET) may cause the staphylococcal
scalded-skin syndrome, Ritter disease, and bullous impe-
tigo [3]. Three serological forms of ET, i.e. ETA, ETB and
ETD have been linked to human pathologies [4]. The in-
vestigation into S. aureus antimicrobial susceptibility pat-
tern presents a research question for national public
health programs in Europe and other countries [5-9]. In-
creasing resistance to antibiotics and the growing preva-
lence of Methicillin Resistant S. aureus (MRSA) can be
connected to antibiotic overuse in primary care and re-
quires to be addressed promptly [10,11]. Ukraine is not
part of the European Union (EU), but it borders several
EU countries. Ukrainian doctors have limited access to
international information and do not take part in
European research programs on epidemiology or bac-
terial drug resistance. Up to now, there has been only
a report in 2009 on the antimicrobial susceptibility
pattern of S. aureus, cultured from clinical samples in
97 surgical wards located in Ukraine [12]. In this study,
the prevalence of MRSA ranged from 10.8% to 84.1%
depending on the location. The authors reported that
it was not possible to evaluate the general consump-
tion of antibiotics outside the hospital environment,
since they could be purchased without medical pre-
scription. The aim of our study was (1) to assess the S.
aureus nasal carriage rate including MRSA strains in
adult Ukrainian population, (2) to determine the anti-
biotic resistant pattern and (3) the occurrence of PVL-,
FnBPA- and ET-encoding genes.
Methods
Patients
Samples were obtained in the South-West Ukraine from
a medical mission organized by the Polish Community
Association in July 2011. Nasal swabs were obtained
from inhabitants of small towns and communities com-
ing for medical consultations. Samples were collected
from both anterior nares by rotating a sterile Amies agar
gel medium transport swab (Oxoid, Basingstoke, UK)
and they were sent to the Department of Clinical Micro-
biology at the Warsaw Medical University (Warsaw,
Poland). Only one isolate from each patient was included
in the study. Each patient completed a standardized ques-
tionnaire including his age, gender, and medical history.
All patients signed the informed consent. This study was
planned and performed in accordance with the Helsinki
Declaration and was approved by the Ethics Committee of
the Polish Community Association. Inclusion criterion
was: age ≥ 18 years. Exclusion criteria were: infections, use
of antibiotics and hospitalization in the three months pre-
ceding the beginning of the study.
S. aureus isolation and identification
Nasal swabs were inoculated directly onto 2 ml of Brain
Heart Infusion (BHI) liquid broth (bioMerieux, Marcy
l’Etoile, France). Samples were incubated for 24 h at 37°C,
then inoculated onto blood agar (Oxoid, Basingstoke,
UK), Chapmann agar (Oxoid, Basingstoke, UK) and finally
onto selective MRSA agar plates (Oxoid, Basingstoke,
UK), which were then incubated for 24–48 h at 37°C.
Identification of S. aureus isolates was completed with
traditional biochemical tests, including Gram-staining,
haemolysis, mannitol fermentation, and the latex slide ag-
glutination test (Staphytect Plus; Oxoid, Basingstoke, UK).
Ambiguous strains were additionally identified with the
Api ID32 Staph test (bioMerieux, Marcy l’Etoile, France)
and the results were read using the ATB-expression sys-
tem (bioMerieux, Marcy l’Etoile, France).
Susceptibility testing
Antibiotic susceptibility testing was performed by disk
diffusion method following the European Committee
on Antimicrobial Susceptibility Testing (EUCAST) guide-
lines. The tested antimicrobial agents were: cefoxitin
(30 μg), gentamicin (10 μg), tetracycline (30 μg),
trimethoprim-sulfamethoxazole (1.25/23.75 μg), erythro-
mycin (15 μg), clindamycin (2 μg), ciprofloxacin (5 μg),
mupirocin (200 μg), rifampicin (5 μg), fusidic acid (10 μg)
and penicillin (1 μg) (all Oxoid, Basingstoke, UK).
Isolates were classified as susceptible or resistant based
on S. aureus epidemiological cut-off values issued
by the EUCAST. Erythromycin-induced clindamycin
resistance was detected by Disk approximation test
(D-test). The reference strain S. aureus ATCC 29213 was
used as internal quality control. The nitrocefine test was
completed using beta-lactamase identification sticks
(Oxoid, Basingstoke, UK). The sizes of inhibition zone di-
ameters were independently read by at least three opera-
tors and then averaged to obtain the final inhibition zone
diameters (in mm).
Polymerase Chain Reaction (PCR)
DNA was extracted using the Genomic DNA Extraction kit
(EURx, Gdansk, Poland) according to the manufacturer’s
guidelines. The cefoxitin-resistant isolates were analyzed
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for the presence of the mecA gene using PCR, as previously
described [13]. PCR, used to detect PVL-, FnBPA-, and ET-
encoding genes, was performed as previously described
[14-17]. Primers and conditions for PCR amplification used
in this study are listed in Table 1.
Statistical analysis
Pearson’s, and Yates’ chi-square tests were used to assess
inter-group significance. Statistical significance was as-
sumed at P < 0.05. Statistical analysis was completed using
Statistica Software version 5.0 (STAT Soft, Cracow,
Poland).
Results
Ninety nine strains of S. aureus were isolated from nasal
swabs taken from 245 adults (184 females, and 61
males). The mean female age was 58.2 ± 17.6 (range: 20–
91). The mean male age was 53.5 ± 18.8 (range: 18–82).
The prevalence of S. aureus nasal carriage was 40.4%
(99/245). Nine out of 99 (9.1%) strains were classified as
MRSA by using the cefoxitin disk diffusion method. All
MRSA isolates tested positive for the mecA gene. The
prevalence of nasal MRSA was 3.7% (9/245). Antimicro-
bial susceptibility profiles and distribution of virulence
factor encoding genes of S. aureus nasal carriage isolates
are presented in Table 2.
Antibiotic susceptibility pattern
All S. aureus strains were susceptible to ciprofloxacin.
No ciprofloxacin- or mupirocin-resistant strains were
detected, but, as far as the level of antimicrobial agent
resistance to mupirocin was concerned, 10.1% (10/99) of
the strains were classified as intermediate. The ability to
produce beta-lactamases was detected in 74.7% (74/99)
of the strains. 77.4% (67/90) of MSSA and 77.8% (7/9)
of MRSA strains resulted positive in the nitrocefin test.
MSSA and MRSA displayed no statistical difference in
beta-lactamase secretion (P > 0.05). 77.8% (70/90) of
MSSA isolates were resistant to penicillin. Resistance to
erythromycin was observed in 10% (9/90), to fusidic acid
and tetracycline in 6.7% (6/90), to gentamicin in 5.5%
(5/90), to clindamycin and rifampicin in 4.4% (4/90), and
to trimethoprim-sulfamethoxazole in 1.1% (1/90) of MSSA
isolates. All MRSA strains were ciprofloxacin-susceptible.
Seven out of 9 (77.8%) MRSA strains were trimethoprim/
sulfamethoxazole-susceptible. Five out of 9 (55.6%) were
susceptible to mupirocin, rifampicin, gentamicin. Eight
strains showed resistance to fusidic acid. 77.8% of those
strains presented resistance to tetracycline, erythromycin,
and clindamycin (7 out of 9, 7 out of 9, and 4 out of 9, re-
spectively). Erythromycin-induced clindamycin resistance
occurred in 3 out of 9 (33.3%) MRSA strains and in 5 out
of 90 (5.6%) MSSA strains. The erythromycin-induced
clindamycin resistance rate was significantly higher among
MRSA strains, if compared with MSSA strains (P < 0.05).
Distribution of virulence factor encoding genes
The virulence factor encoding genes were detected in
79.8% (79/99) of the isolates. Among the 99 strains, the
fnbA gene was detected in over 59% of the strains, lukS-
lukF genes in over 58% and ET-encoding genes in over
39%. The lukS-lukF genes were detected in 55.5% (5/9)
of MRSA and in 58.9% (53/90) of MSSA strains. LukS-
lukF genes and the etd gene were most commonly co-
present in MRSA strains, whereas lukS-lukF genes and
the fnbA gene were most commonly co-present in
MSSA strains. No significant difference was detected be-
tween the occurrence of lukS-lukF genes (P > 0.05) and
the etd gene (P > 0.05), whereas the occurrence of the
fnbA gene was significantly more frequent in MSSA
strains (P < 0.05).
Table 1 Primers used for detection of PVL-, FnBPA-, and ET-encoding genes by PCR
Gene Primer Primer sequence (5’ – 3’) Amplicon size (bp) Reference
mecA mecA-F GTAGAAATGACTGAACGTCCGATAA 310 McClure et al. 2006 [13]
mecA-R CCAATTCCACATTGTTTCGGTCTAA
fnbA fnbA-F CACAACCAGCAAATATAG 1362 Peacock et al. 2002 [14]
fnbA-R CTGTGTGGTAATCAATGTC
eta eta-F ACTGTAGGAGCTAGTGCATTTGT 190 Jarraud et al. 2002 [15]
eta-R TGGATACTTTTGTCTATCTTTTTCATCAAC
etb etb-F ATACACACATTACGGATAAT 629 Yamaguchi et al. 2001 [16]
etb-R CAAAGTGTCTCCAAAAGTAT
etd etd - F CGCAAATACATATGAAGAATCTGA 452 Nakaminami et al. 2008 [17]
etd - R TGTCACCTTGTTGCAAATCTATAG
PVL components S and F lukS-PV- AGTGAACTTATCTTTCTATTGAAAAACACTC 433 Jarraud et al. 2002 [15]
lukF-PV GCATCAASTGTATTGGATAGCAAAAGC
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Cefoxitin Clindamycin Erythromycin MLSB lukPV eta etb etd fnbA
MSSA
1 S S S S S S S S S S S +
2 + S S S S S S R S S S S
3 + S S S S S S R S S S S + +
4 + S S S S S S R S S S S
5 + R S R R S S R S S R R +
6 + S S S S S S R S S S S + + +
7 + S S S S S S R S S S S + + +
8 + S S S S S S R S S S S + +
9 + S S S S S S R S S S S + + +
10 + S S S S S S R S S S S + +
11 + S I R S S S R S S S S +
12 S S S S S S S S S S S +
13 + S S S S S S R S S S S + +
14 + S S S S S S R S S S S + +
15 + S S S S S S R S S S R + + + +
16 + S S S S S S R S S S S + + +
17 + R S R S S I R S S R R + + +
18 + S S S S S S R S S S S + +
19 S S S S S S S S S S S + +
20 S S S S S S S S S S S
21 + S S S S S S R S S S S + + +
22 + S S S S S S R S S S S + +
23 + R S S R S S R S S S R + + +
24 + S S S S S S R S S S S
25 S S S S S S S S S S S +
26 S S S S S S S S S S S +




















Table 2 Staphylococcus aureus nasal carriage isolates: antimicrobial susceptibility profiles and distribution of virulence factor encoding genes (Continued)
28 + S I S S S S R S S S S + +
29 + S S S R S S R S S S S
30 S S S S S S S S S S S + +
31 + S S S S S S R S S S S
32 S S S S S S R S S S S + +
33 S S S S S S S S S S S + +
34 + S S S S S S R S S S R + + +
35 + S S S S S S R S S S S + +
36 + S I S R S S R S S S S +
37 + S S S S S S R S S S S
38 + S S S S S S R S S S S +
39 + S S S S S S R S S S S + +
40 S S S S S S S S S S S + + +
41 + S S S S S S R S S S S +
42 S S R S S S S S S S S
43 + S S S S S S R R S S S + + +
44 + S S S S S S R S S S S + +
45 + S S S S S S R S S S S + +
46 + S S S S S S R S S S S + +
47 + S S S S S S R S S S S +
48 + S S S S S S R S S S S
49 + S S S S S S R S S S S + + +
50 + R S S S S S R R S S R + + +
51 + S S S S S S R S S S S + +
52 S S S S S S S S S S S + +
53 + S S S S S S R S S S S +
54 + S S S S S S R S S S S +
55 + S S S S S S R S S S S + +
56 + S S S S S S R S S S S +
57 + S S S S S S R R S R S + + +




















Table 2 Staphylococcus aureus nasal carriage isolates: antimicrobial susceptibility profiles and distribution of virulence factor encoding genes (Continued)
59 + S S S S S S R S S S S + + +
60 + S S S S S S R S S S S
61 + S S S S S S R S S S S + +
62 + S S S S S S R S S S S + + +
63 + S S S S S S R S S S S + +
64 + S S S S S S R S S S S + +
65 S S S S S S S S S S S
66 + S S S S S S R S S S S +
67 + S S S S S S R S S S S + + +
68 + S S S S S S R S S S S
69 S S S S S S S S S S S
70 S S S S S S S S S S S + +
71 + S S S S S S R R S S S + + +
72 + S S S S S S R S S S S +
73 + S S S S S S R S S S S
74 + S S S S S S R S S S S + + +
75 + S S S S S S R S S S S + +
76 + S S S S S S R S S S S + +
77 S S S S S S S S S S S + +
78 S S S S S S R S S S S + +
79 S S S S S S S S S S S +
80 + S S S S S S R S S S S + +
81 + S S S S S S R R S S S + + +
82 S I S S S S S S S S S +
83 S S S S S S S S S S R +
84 + S S S S S S R S S S S +
85 S S S S S S S S S S S + +
86 + R S S S S R R R S S R + +
87 + S S S S S S R S S S S
88 + S S S S S S R S S S S
89 + S S S S S S R S S S S




















Table 2 Staphylococcus aureus nasal carriage isolates: antimicrobial susceptibility profiles and distribution of virulence factor encoding genes (Continued)
MRSA
1 + S S S R S S R R R S R + +
2 R I S R S I R R R R R
3 + S S R R S S R R R S R + +
4 + R I I R S R R R R R R
5 + S S S R S S R R R S R + + +
6 + R I R S S S R R R R S + +
7 S S S R S S R R R S R + + +
8 + S S S S S S R R R S S + + +
9 + R I R R S S R S R R R





















There is no evidence of S. aureus susceptibility and occur-
rence of virulence encoding genes within the Ukrainian
population. The present study reports that the prevalence
of S. aureus nasal carriage in Ukraine was 40.4%, whereas
MRSA carriage was 3.7%. In general, S. aureus nasal car-
riage rate in Ukraine is higher than in most countries in
Europe, Africa, Asia, North and South America and
Oceania [5-7,18-23]. In our study, neither MSSA nor
MRSA ciprofloxacin resistant strains were observed using
the disk diffusion method. These data differ from the data
concerning other countries [5,7,18,23]. The absence of
ciprofloxacin resistant strains can be explained by their
limited use in Ukraine. In this study the ET-encoding
genes were found in about 40% of S. aureus strains. The
most prevalent serotype was ETD. Our data differ from
the data concerning other European, American, and African
countries, where the ETA serotype is prevalent and de-
tected in more than 80% of toxin-producing strains
[24-26]. Only in Japan, ETB-producing strains are more
prevalent than those expressing ETA [27]. In this study,
no significant difference was detected in the occurrence of
ET-encoding genes between MRSA and MSSA. Other
studies have suggested that the etb gene was found pri-
marily in strains with mecA, while the eta gene was mainly
found in strains without mecA [15]. The prevalence of
fnbA-positive S. aureus in healthy Ukrainian adults is
lower, if compared to its prevalence in other countries
[28]. In the present study, FnBPA-encoding gene was de-
tected in over 59% of strains, whereas the occurrence of
the fnbA gene was more frequent in the MSSA. We found
a high prevalence of PVL encoding genes. Over 58%
strains isolated from nares in individuals with no staphylo-
coccal infection symptoms, were luk-PV-positive. This evi-
dence contrasts with previous reports. For instance, the
prevalence of PVL-positive S. aureus nasal colonization in
Dutch general practice patients was 0.6% [5]. Furthermore,
a PVL prevalence of 38.9% was observed in S. aureus and
it caused abscesses, arthritis, and soft-tissue infections [5].
The prevalence of PVL-positive S. aureus in nasal
colonization was 2.4% in the United States. The data were
obtained as part of the National Health and Nutrition
Examination Survey [6]. It was estimated that PVL-
positive S. aureus was more prevalent pathogen in the tro-
pics and subtropics, if compared with European countries
[29]. The PVL genes were detected in 10.6% methicillin
sensitive S. aureus strains in the Indonesian population
[30]. A similar PVL-positive percentage (around 57%) was
discovered in an African study of five cities in Cameroon,
Morocco, Madagascar, Niger and Senegal. However, the
tested group consisted of individuals with an already di-
agnosed staphylococcal infection [31]. Therefore, the
PVL-positive percentage in the Ukrainians with staphylo-
coccal infection symptoms would be significantly higher.
Travellers to tropical and subtropical countries are ex-
posed to a higher risk of skin and soft-tissue infections.
This phenomenon results from a higher PVL-positive S.
aureus occurrence in tropical and subtropical countries
[31]. Similarly, job seekers travelling from Ukraine could
be a source of toxin-producing strains.
Conclusions
In our cohort of Ukrainian patients, we found that the
prevalence of S. aureus nasal carriage was 40.4%. 9.1% of
the strains were classified as MRSA and all MRSA iso-
lates tested positive for the mecA gene. The prevalence
of nasal MRSA was 3.7%. We also found a high preva-
lence of PVL- and ET-encoding genes among S. aureus
nasal carriage strains. A limitation of our study is that
we studied isolates deriving only from the South-West
Ukraine and it cannot be representative of the overall
Ukrainian situation. Furthermore, we did not perform
spa typing and therefore we could not discriminate
among different strains of S. aureus. Further studies are
required to address those limitations. A systematic sur-
veillance system can help prevent transmission and spread
of drug resistant toxin producing S. aureus strains.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
IN designed the study, collected samples and data, performed
microbiological and molecular testing and data analysis, interpreted the
results, participated in the drafting of the article and obtained funding; MF
designed and coordinated the study, collected samples, interpreted the
results, analysed the data and obtained funding; KP collected data,
performed microbiological and molecular testing, participated in the drafting
of the article and obtained funding; MG collected data, performed
microbiological and molecular tests and participated in the drafting of the
article; MS collected data, performed microbiological and molecular tests
and participated in the drafting of the article; AM analyzed the data and
participated in the drafting of the article; ES-K coordinated the study and
performed data analysis; WM performed data analysis and coordinated the
study; BP designed and coordinated the study; TI supervised and
coordinated the study, performed data analysis and participated in the
drafting of the article. All authors read and approved the final version of the
manuscript.
Acknowledgments
This article was not supported by grants. We thank the Polish Community
Association for the organization and financial support.
Statement of authorship
The authors hereby certify that all work contained in this article is original.
The authors claim full responsibility for the contents of the article.
Author details
1Department of Medical Microbiology, Warsaw Medical University, Warsaw,
Poland. 2Chair and Department of General,Transplant and Liver Surgery,
Warsaw Medical University, Warsaw, Poland. 3Department of Dentistry
Microbiology, Warsaw Medical University, Warsaw, Poland. 4Academy of Face
Sculpturing, Warsaw, Poland. 5Department of General Surgery and Surgical
Specialties, University of Modena and Reggio Emilia Medical School, Surgical
Clinic, Modena, Italy. 6School of Biomedical Sciences, University of Leeds,
Mount Preston Street, Garstang building, LS2 9JT Leeds, UK.
Netsvyetayeva et al. BMC Infectious Diseases 2014, 14:128 Page 8 of 9
http://www.biomedcentral.com/1471-2334/14/128
Received: 11 June 2013 Accepted: 3 February 2014
Published: 5 March 2014
References
1. Edwards AM, Potter U, Meenan NA, Potts JR, Massey RC: Staphylococcus
aureus keratinocyte invasion is dependent upon multiple high-affinity
fibronectin-binding repeats within FnBPA. PloS One 2011, 6(4):e18899.
2. Boyle-Vavra S, Daum RS: Community-acquired methicillin-resistant
Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab
Investig J Tech Met Pathol 2007, 87(1):3–9.
3. Farrell AM: Staphylococcal scalded-skin syndrome. Lancet 1999,
354(9182):880–881.
4. Yamaguchi T, Nishifuji K, Sasaki M, Fudaba Y, Aepfelbacher M, Takata T,
Ohara M, Komatsuzawa H, Amagai M, Sugai M: Identification of the
Staphylococcus aureus etd pathogenicity island which encodes a novel
exfoliative toxin, ETD, and EDIN-B. Infect Immun 2002, 70(10):5835–5845.
5. Donker GA, Deurenberg RH, Driessen C, Sebastian S, Nys S, Stobberingh EE:
The population structure of Staphylococcus aureus among general
practice patients from The Netherlands. Clin Microbiol Infect Off Pub Eur
Soc Clin Microbiol Infect Dis 2009, 15(2):137–143.
6. Kuehnert MJ, Kruszon-Moran D, Hill HA, McQuillan G, McAllister SK, Fosheim G,
McDougal LK, Chaitram J, Jensen B, Fridkin SK, Killgore G, Tenover FC:
Prevalence of Staphylococcus aureus nasal colonization in the United
States, 2001–2002. J Infect Dis 2006, 193(2):172–179.
7. Munckhof WJ, Nimmo GR, Schooneveldt JM, Schlebusch S, Stephens AJ,
Williams G, Huygens F, Giffard P: Nasal carriage of Staphylococcus aureus,
including community-associated methicillin-resistant strains, in
Queensland adults. Clin Microbiol Infect Off Pub Eur Soc Clin Microbiol Infect
Dis 2009, 15(2):149–155.
8. van Bijnen EM, den Heijer CD, Paget WJ, Stobberingh EE, Verheij RA,
Bruggeman CA, Pringle M, Goossens H, Schellevis FG: The appropriateness
of prescribing antibiotics in the community in Europe: study design.
BMC Infect Dis 2011, 11:293.
9. Witte W: Community-acquired methicillin-resistant Staphylococcus aureus:
what do we need to know? Clin Microbiol Infect Off Pub Eur Soc Clin Microbiol
Infect Dis 2009, 15(Suppl 7):17–25.
10. Goossens H, Ferech M, Vander Stichele R, Elseviers M: Outpatient antibiotic
use in Europe and association with resistance: a cross-national database
study. Lancet 2005, 365(9459):579–587.
11. Seppala H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P: Outpatient use
of erythromycin: link to increased erythromycin resistance in group A
streptococci. Clin Infect Dis Off Pub Infect Dis Soc Am 1995, 21(6):1378–1385.
12. Mariievs'kyi VF, Poliachenko Iu V, Salmanov AH, Shpak IV, Doan SI:
Resistance to antibiotics of nosocomial cultures of Staphylococcus
aureus in surgical departments of Ukraine in 2009 year. Klin Khir 2010,
9:31–35.
13. McClure JA, Conly JM, Lau V, Elsayed S, Louie T, Hutchins W, Zhang K: Novel
multiplex PCR assay for detection of the staphylococcal virulence marker
Panton-Valentine leukocidin genes and simultaneous discrimination of
methicillin-susceptible from -resistant staphylococci. J Clin Microbiol 2006,
44(3):1141–1144.
14. Peacock SJ, Moore CE, Justice A, Kantzanou M, Story L, Mackie K, O'Neill G,
Day NP: Virulent combinations of adhesin and toxin genes in natural
populations of Staphylococcus aureus. Infect Immun 2002, 7(9):4987–4996.
15. Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F, Nesme X,
Etienne J, Vandenesch F: Relationships between Staphylococcus aureus
genetic background, virulence factors, agr groups (alleles), and human
disease. Infect Immun 2002, 70(2):631–641.
16. Yamaguchi T, Hayashi T, Takami H, Ohnishi M, Murata T, Nakayama K,
Asakawa K, Ohara M, Komatsuzawa H, Sugai M: Complete nucleotide
sequence of a Staphylococcus aureus exfoliative toxin B plasmid and
identification of a novel ADP-ribosyltransferase, EDIN-C. Infect Immun
2001, 69(12):7760–7771.
17. Nakaminami H, Noguchi N, Ikeda M, Hasui M, Sato M, Yamamoto S, Yoshida T,
Asano T, Senoue M, Sasatsu M: Molecular epidemiology and antimicrobial
susceptibilities of 273 exfoliative toxin-encoding-gene-positive
Staphylococcus aureus isolates from patients with impetigo in Japan.
J Med Microbiol 2008, 57(Pt 10):1251–1258.
18. Ben Slama K, Gharsa H, Klibi N, Jouini A, Lozano C, Gomez-Sanz E, Zarazaga
M, Boudabous A, Torres C: Nasal carriage of Staphylococcus aureus in
healthy humans with different levels of contact with animals in Tunisia:
genetic lineages, methicillin resistance, and virulence factors. Eur J Clin
Microbiol Infect Dis Off Pub Eur Soc Clin Microbiol 2011, 30(4):499–508.
19. Boucher HW, Corey GR: Epidemiology of methicillin-resistant Staphylococcus
aureus. Clin Infect Dis Off Pub Infect Dis Soc Am 2008, 46(Suppl 5):S344–S349.
20. Du J, Chen C, Ding B, Tu J, Qin Z, Parsons C, Salgado C, Cai Q, Song Y, Bao Q,
Zhang L, Pan J, Wang L, Yu F: Molecular characterization and antimicrobial
susceptibility of nasal Staphylococcus aureus isolates from a Chinese
medical college campus. PloS One 2011, 6(11):e27328.
21. Farley JE, Ross T, Stamper P, Baucom S, Larson E, Carroll KC: Prevalence, risk
factors, and molecular epidemiology of methicillin-resistant Staphylococcus
aureus among newly arrested men in Baltimore, Maryland. Am J Infect
Contr 2008, 36(9):644–650.
22. Kottler S, Middleton JR, Perry J, Weese JS, Cohn LA: Prevalence of
Staphylococcus aureus and methicillin-resistant Staphylococcus aureus
carriage in three populations. J Vet Intern Med 2010, 24(1):132–139.
23. Lu PL, Chin LC, Peng CF, Chiang YH, Chen TP, Ma L, Siu LK: Risk factors and
molecular analysis of community methicillin-resistant Staphylococcus
aureus carriage. J Clin Microbiol 2005, 43(1):132–139.
24. Adesiyun AA, Lenz W, Schaal KP: Exfoliative toxin production by
Staphylococcus aureus strains isolated from animals and human beings
in Nigeria. Microbiologica 1991, 14(4):357–362.
25. Cribier B, Piemont Y, Grosshans E: Staphylococcal scalded skin syndrome
in adults. A clinical review illustrated with a new case. J Am Acad
Dermatol 1994, 30(2 Pt 2):319–324.
26. de Azavedo J, Arbuthnott JP: Prevalence of epidermolytic toxin in clinical
isolates of Staphylococcus aureus. J Med Microbiol 1981, 14(3):341–344.
27. Yamasaki O, Yamaguchi T, Sugai M, Chapuis-Cellier C, Arnaud F, Vandenesch
F, Etienne J, Lina G: Clinical manifestations of staphylococcal scalded-skin
syndrome depend on serotypes of exfoliative toxins. J Med Microbiol
2005, 43(4):1890–1893.
28. Melles DC, Gorkink RF, Boelens HA, Snijders SV, Peeters JK, Moorhouse MJ,
van der Spek PJ, van Leeuwen WB, Simons G, Verbrugh HA, van Belkum A:
Natural population dynamics and expansion of pathogenic clones of
Staphylococcus aureus. J Clin Invest 2004, 114(12):1732–1740.
29. Zanger P, Nurjadi D, Schleucher R, Scherbaum H, Wolz C, Kremsner PG,
Schulte B: Import and spread of Panton-Valentine Leukocidin-positive
Staphylococcus aureus through nasal carriage and skin infections in
travelers returning from the tropics and subtropics. Clin Infect Dis Off
Pub Infect Dis Soc Am 2012, 54(4):483–492.
30. Severin JA, Lestari ES, Kuntaman K, Melles DC, Pastink M, Peeters JK, Snijders
SV, Hadi U, Duerink DO, van Belkum A, Verbrugh HA: Unusually high
prevalence of panton-valentine leukocidin genes among methicillin-
sensitive Staphylococcus aureus strains carried in the Indonesian
population. J Clin Microbiol 2008, 46(6):1989–1995.
31. Breurec S, Fall C, Pouillot R, Boisier P, Brisse S, Diene-Sarr F, Djibo S, Etienne J,
Fonkoua MC, Perrier-Gros-Claude JD, Ramarokoto CE, Randrianirina F,
Thiberge JM, Zriouil SB, Garin B, Laurent F, Working Group on
Staphylococcus aureus Infections: Epidemiology of methicillin-
susceptible Staphylococcus aureus lineages in five major African
towns: high prevalence of Panton-Valentine leukocidin genes. Clin
Microbiol Infect Off Pub Eur Soc Clin Microbiol Infect Dis 2011,
17(4):633–639.
doi:10.1186/1471-2334-14-128
Cite this article as: Netsvyetayeva et al.: Staphylococcus aureus nasal
carriage in Ukraine: antibacterial resistance and virulence factor
encoding genes. BMC Infectious Diseases 2014 14:128.
Netsvyetayeva et al. BMC Infectious Diseases 2014, 14:128 Page 9 of 9
http://www.biomedcentral.com/1471-2334/14/128
